X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

期刊標題檢索 PHARMACOEPIDEM 最新評論: Review speed: 6.0 | Submission success rate: 25.0 Experience sharing... (2024-05-22)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[PHARMACOEPIDEMIOLOGY AND DRUG SAFETY]您好,您是該頁面的第 18726 位訪客。

期刊簡介
期刊名稱PHARMACOEPIDEMIOLOGY AND DRUG SAFETY PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
LetPub Score
6.3
50 ratings
Rate

Reputation
7.5

Influence
5.2

Speed
7.0

期刊簡稱PHARMACOEPIDEM DR S
ISSN1053-8569
E-ISSN1099-1557
h-index85
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.801.1061.000
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q2105 / 272
Category: Medicine
Subcategory: Epidemiology
Q263 / 148

自引率 (2023-2024)4.20%自引率趨勢
掲載範囲
The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report.

Particular areas of interest include:

design, analysis, results, and interpretation of studies looking at the benefit or safety of specific pharmaceuticals, biologics, or medical devices, including studies in pharmacovigilance, postmarketing surveillance, pharmacoeconomics, patient safety, molecular pharmacoepidemiology, or any other study within the broad field of pharmacoepidemiology;

comparative effectiveness research relating to pharmaceuticals, biologics, and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as these methods are truly used in the real world;

methodologic contributions of relevance to pharmacoepidemiology, whether original contributions, reviews of existing methods, or tutorials for how to apply the methods of pharmacoepidemiology;

assessments of harm versus benefit in drug therapy;

patterns of drug utilization;

relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines;

evaluations of risk management plans and programmes relating to pharmaceuticals, biologics and medical devices.
官方網站http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1557
在線稿件提交http://mc.manuscriptcentral.com/pds
開放訪問No
出版商John Wiley and Sons Ltd
主題領域医学
出版國/地區ENGLAND
發行頻率隔月刊行
創刊年1992
每年文章數137每年文章數趨勢
黃金OA百分比31.52%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ3188/354
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTHSCIEQ2163/403
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1053-8569%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 3 Month(s)
競爭力 *來自作者的數據: About 75%
參考鏈接
相關期刊 【PHARMACOEPIDEMIOLOGY AND DRUG SAFETY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498329
    PHYTOMEDICINE340268
    LIFE SCIENCES285765
    International Journal of Pharmaceutics242440
    PHARMACOLOGICAL RESEARCH241282
    European Journal of Pharmacology204248
    BIOCHEMICAL PHARMACOLOGY202693
    JOURNAL OF NATURAL PRODUCTS196695
    BRITISH JOURNAL OF PHARMACOLOGY165140
    MOLECULAR PHARMACEUTICS162833
  •  

    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [PHARMACOEPIDEMIOLOGY AND DRUG SAFETY] 的評論撰寫評論
作者: 极乐问文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-22 19:22:46 評論於
Review speed: 6.0 | Submission success rate: 25.0
Experience sharing: I waited over 3 months for my submission, only to be rejected with feedback from just one reviewer. They criticized my lack of explanation for setting the threshold, using classic analysis methods. It's so unfortunate that I didn't even get a chance to revise. The wait was too long
(0) 讚! | 极乐问文

作者: weibos


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2023-10-30 13:20:03 評論於
Pharmacovigilance and Drug Safety: This is a very famous journal in the field of pharmacovigilance and real-world research, with many industry representative articles. Although the impact factor is not high, the editors and reviewers are very responsible and reply quickly. Generally, results are available within one to two months. It is not so easy to get accepted
(0) 讚! | weibos

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 17:20:31 評論於
Present the research results according to the order of research questions and hypotheses, or you can also structure the research results according to the order of research methods. Using the chronological order of years and months as the arrangement sequence, arranging based on importance, or categorizing by different themes are all efficient methods. When determining the structure of presenting research results, it is necessary to consider the readers, basis, and most importantly, the research objectives
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:59:51 評論於
Please translate the following paragraph into English and Japanese, and use ":" and ":" as titles: Delete unnecessary parts based on the central content of the article
(0) 讚! | 维尔娜菲茨杰拉德

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 20:20:54 評論於
I have too many results, the article cannot contain everything, what should I do?
(0) 讚! | 陶宜三岁啦

作者: Oswald Edie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 20:02:39 評論於
What kind of logical order should be followed when organizing the results?
(0) 讚! | Oswald Edie

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 12:43:41 評論於
It keeps falling, will it break 2 soon? It has dropped quite a bit in just a year, even 0.1 point should be cherished
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-09-23 21:21:44 評論於
Review speed: 3.0 | Submission acceptance rate: 5.0
Sharing of experience: The speed is very slow, it took 4 months to get a response
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-09-23 16:28:52 評論於
Review speed: 3.0 | Submission hit rate: 5.0
Experience sharing: Found an American company for polishing, but was rejected for language reasons, thinking it's just an excuse
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-07-01 09:59:31 評論於
This journal is now rated 2.5, which is a significant increase from last year. Is there hope that we can reach 3?
(0) 讚! | 凌霄高洁

作者: 孤云平彤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-03-09 16:37:41 評論於
Is there a layout fee?
(0) 讚! | 孤云平彤

作者: 藤原惠美


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-01-24 21:45:22 評論於
Review Speed: 3.0 | Submission Acceptance Rate: 75.0 Experience Sharing: This is a pretty good journal, the review process is fast, and the main articles are of high quality. Content is more important than anything else. Additionally, this journal has an Asian editor (from Korea) in charge of Asian submissions, making it less likely to face discrimination
(0) 讚! | 藤原惠美

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [PHARMACOEPIDEMIOLOGY AND DRUG SAFETY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*